|
Amarin Falls After U.S. Approval Limits Debut Drug’s Use
U.S. approval for Amarin’s first product, a drug to combat high levels of blood fat that can lead to stroke and heart attack, included limits on its use that may have disappointed investors.
Businessweek |
Register Now
Archives